Featured Research

from universities, journals, and other organizations

Immune Cells May Help Deliver Cancer Vaccines For Children; Cell Culture Research Could Tap Potential Of Immune System In Fighting Cancer

Date:
May 5, 2003
Source:
Childrens Hospital Of Philadelphia
Summary:
In a finding that could lay the groundwork for future cancer vaccines for children, cancer researchers working in cell culture have shown that modified immune cells can efficiently deliver genetic material to stimulate a desirable immune response.

In a finding that could lay the groundwork for future cancer vaccines for children, cancer researchers working in cell culture have shown that modified immune cells can efficiently deliver genetic material to stimulate a desirable immune response.

Researchers from The Children's Hospital of Philadelphia and the Abramson Family Cancer Research Institute at the University of Pennsylvania manipulated immune cells called CD40-activated B cells to carry RNA produced by tumors and viruses. The RNA, which carries genetic codes from DNA, was obtained either from tumor or viral proteins. The researchers adapted an approach used in research on adults to one more appropriate for children.

The research team found that the B cells carrying the RNA "payloads" stimulated other blood cells to produce cytotoxic T lymphocytes: immune cells with the potential to kill invading cells. "This response could form the basis of a cancer vaccine that stimulates the body's existing immune system," said Christina M. Coughlin, M.D., Ph.D., who presented the research today at the annual conference of the Pediatric Academic Societies in Seattle.

Unlike routine childhood vaccinations such as those given to prevent the onset of infectious diseases such as polio or measles, cancer vaccines would be therapeutic vaccines, given to treat a disease that a patient already has.

Therapeutic cancer vaccines are currently being tested against a wide variety of malignancies, mostly in adult patients. Although none of these vaccines is yet approved by the U.S. Food and Drug Administration, one promising approach in adults uses dendritic cells extracted from the patient's own blood and formulated into a vaccine.

However, it has been technically difficult to retrieve sufficient dendritic cells from small children. Instead, the Philadelphia research team used CD40-B cells, which were extracted in small amounts from a child's blood, then grown in the laboratory. Both dendritic cells and CD40-B cells are antigen-presenting cells, whose function is to bring microorganisms and cancer cells to the attention of the body's immune system.

The finding reported today does not yet have an immediate clinical application. "What we know now is that we may have found a useful delivery system for the time when cancer vaccines are tested in children," said Dr. Coughlin, who is a research fellow from The Children's Hospital of Philadelphia, working in the laboratory of Robert H. Vonderheide, M.D., D.Phil., of Penn's Abramson Family Cancer Research Institute.

Pediatric oncologist Stephan A. Grupp, M.D., Ph.D., director of Stem Cell Biology at The Children's Hospital of Philadelphia, was the third member of the research team. "Our current work may eventually support immune-boosting therapies against pediatric cancers, such as neuroblastoma," said Dr. Grupp. Neuroblastoma, a solid tumor of the peripheral nervous system, accounts for 10 percent of all childhood cancers. It is a major research focus of the Oncology Program at Children's Hospital, one of the largest pediatric cancer programs in the United States.

###

Founded in 1855 as the nation's first pediatric hospital, The Children's Hospital of Philadelphia is ranked today as he best pediatric hospital in the nation by a comprehensive Child magazine survey. Through its long-standing commitment to providing exceptional patient care, training new generations of pediatric healthcare professionals and pioneering major research initiatives, Children's Hospital has fostered many discoveries that have benefited children worldwide. Its pediatric research program is among the largest in the country, ranking second in National Institutes of Health funding. In addition, its unique family-centered care and public service programs have brought the 381-bed hospital recognition as a leading advocate for children and adolescents from before birth through age 19.

For more information, visit http://www.chop.edu.

Established in 1997, the Abramson Family Cancer Research Institute integrates innovative cancer research, education, and patient care at the Abramson Cancer Center of the University of Pennsylvania. The Institute strives to accelerate the translation of laboratory discoveries into clinical treatments.

The Abramson Cancer Center was among the first in the nation to become an NCI-designated Comprehensive Cancer Center. For more information on research at the Abramson Family Cancer Institute, visit http://www.uphs.upenn.edu/abramson. For cancer information written for patients by specialists at the Abramson Cancer Center, visit http://www.oncolink.com.


Story Source:

The above story is based on materials provided by Childrens Hospital Of Philadelphia. Note: Materials may be edited for content and length.


Cite This Page:

Childrens Hospital Of Philadelphia. "Immune Cells May Help Deliver Cancer Vaccines For Children; Cell Culture Research Could Tap Potential Of Immune System In Fighting Cancer." ScienceDaily. ScienceDaily, 5 May 2003. <www.sciencedaily.com/releases/2003/05/030505083931.htm>.
Childrens Hospital Of Philadelphia. (2003, May 5). Immune Cells May Help Deliver Cancer Vaccines For Children; Cell Culture Research Could Tap Potential Of Immune System In Fighting Cancer. ScienceDaily. Retrieved July 25, 2014 from www.sciencedaily.com/releases/2003/05/030505083931.htm
Childrens Hospital Of Philadelphia. "Immune Cells May Help Deliver Cancer Vaccines For Children; Cell Culture Research Could Tap Potential Of Immune System In Fighting Cancer." ScienceDaily. www.sciencedaily.com/releases/2003/05/030505083931.htm (accessed July 25, 2014).

Share This




More Health & Medicine News

Friday, July 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

AFP (July 24, 2014) A so-called drugs rehab 'clinic' is closed down in Pakistan after police find scores of ‘patients’ chained up alleging serial abuse. Duration 03:05 Video provided by AFP
Powered by NewsLook.com
Too Few Teens Receiving HPV Vaccination, CDC Says

Too Few Teens Receiving HPV Vaccination, CDC Says

Newsy (July 24, 2014) The Centers for Disease Control and Prevention is blaming doctors for the low number of children being vaccinated for HPV. Video provided by Newsy
Powered by NewsLook.com
New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins